SecSonar.com

Legend Biotech Corporation (LEGN)

Legend Biotech Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Legend Biotech Corporation (LEGN) is a Biotechnology company based in US with a market capitalization of $5B. Revenue grew 64.0% year-over-year and free cash flow was negative at -$168M. This page tracks LEGN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.6K employees · IPO Jun 5, 2020

Valuation

Valuation & price

$27.55 · as of May 17, 2026 · -37.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

5.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$44.32$30.48$16.65Jul 25Dec 25Jul 26Jul 7, 25$35.87Jul 9, 25$39.46Jul 11, 25$38.96Jul 15, 25$39.59Jul 17, 25$42.13Jul 21, 25$42.23Jul 23, 25$44.32Jul 25, 25$43.36Jul 29, 25$40.77Jul 31, 25$39.07Aug 4, 25$38.45Aug 6, 25$37.66Aug 11, 25$36.24Aug 13, 25$36.93Aug 15, 25$37.50Aug 19, 25$36.54Aug 21, 25$35.53Aug 25, 25$34.60Aug 27, 25$34.72Aug 29, 25$34.73Sep 3, 25$35.95Sep 5, 25$36.08Sep 9, 25$34.25Sep 11, 25$33.83Sep 16, 25$34.34Sep 18, 25$35.16Sep 22, 25$34.08Sep 24, 25$32.88Sep 26, 25$33.37Sep 30, 25$32.61Oct 2, 25$32.29Oct 6, 25$31.44Oct 8, 25$32.21Oct 10, 25$31.70Oct 14, 25$33.23Oct 16, 25$32.36Oct 21, 25$32.86Oct 23, 25$31.67Oct 27, 25$32.12Oct 29, 25$32.13Oct 31, 25$32.40Nov 4, 25$32.05Nov 6, 25$32.37Nov 10, 25$31.59Nov 12, 25$31.18Nov 14, 25$30.29Nov 18, 25$29.42Nov 20, 25$27.53Nov 25, 25$28.19Nov 28, 25$27.71Dec 2, 25$26.69Dec 4, 25$27.81Dec 8, 25$26.12Dec 10, 25$23.36Dec 12, 25$22.32Dec 16, 25$21.65Dec 18, 25$21.28Dec 22, 25$22.69Dec 24, 25$22.98Dec 29, 25$21.92Jan 2, 26$21.51Jan 6, 26$20.98Jan 8, 26$23.03Jan 12, 26$23.70Jan 14, 26$23.28Jan 16, 26$22.14Jan 21, 26$20.76Jan 23, 26$19.01Jan 27, 26$18.27Jan 29, 26$17.72Feb 2, 26$17.15Feb 4, 26$16.65Feb 9, 26$17.19Feb 11, 26$18.54Feb 13, 26$17.58Feb 18, 26$18.35Feb 20, 26$18.12Feb 24, 26$19.50Feb 26, 26$19.28Mar 2, 26$18.44Mar 4, 26$17.85Mar 6, 26$18.97Mar 10, 26$19.56Mar 12, 26$19.05Mar 17, 26$18.55Mar 19, 26$17.87Mar 23, 26$17.23Mar 25, 26$17.60Mar 27, 26$16.80Mar 31, 26$18.09Apr 2, 26$19.14Apr 7, 26$17.99Apr 9, 26$18.20Apr 13, 26$17.69Apr 15, 26$20.52Apr 17, 26$21.17Apr 22, 26$25.93Apr 24, 26$23.90Apr 28, 26$23.56Apr 30, 26$23.52May 4, 26$26.50May 6, 26$28.96May 8, 26$28.12May 12, 26$28.26May 14, 26$28.60May 18, 26$26.98May 20, 26$28.12May 22, 26$29.37May 28, 26$28.26Jun 1, 26$25.51Jun 3, 26$35.98Jun 5, 26$32.62Jun 9, 26$33.49Jun 11, 26$36.28Jun 15, 26$35.48Jun 17, 26$33.52Jun 22, 26$29.34Jun 24, 26$29.38Jun 26, 26$28.69Jul 2, 26$29.66
$16.6552-week range$44.32
Loading valuation history…

Fundamentals

Key fundamentals

$5B

Market cap

64.0%

Revenue growth (YoY)

60.3%

Gross margin

-$168M

Free cash flow (USD)

-$534.9M

Net debt

Net cash position

0.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$23.6MFY 2018$49.1MFY 2019$61.8MFY 2020$75.0MFY 2021$68.8MFY 2022$117.0MFY 2023$285.1MFY 2024$627.2MFY 2025$1.0B
$23.6M$1B

Free cash flow by year

2017 → 2025

FY 2017$-3.3MFY 2018$286.7MFY 2019$-122.2MFY 2020$-253.3MFY 2021$-243.9MFY 2022$-223.6MFY 2023$-416.0MFY 2024$-158.1MFY 2025$-168.0M
-$3.3M-$168M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 202244.1%FY 202349.4%FY 202462.6%FY 202560.3%
100.0%60.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 6-K filed Jun 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $82KHuang Ying · Director, Chief Executive Officer · $82.3KJun 29, 2026Filing
  • 6-K filingCapital RaiseJun 22, 2026Filing
  • 6-K filingEHA 2026 RecapJun 15, 2026Filing
  • 6-K filingClinical Data PresentationJun 2, 2026Filing
  • Annual reportAnnual Report FiledJun 1, 2026Filing
  • 6-K filingASCO 2026 PresentationsMay 21, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 12, 2026Filing
  • Annual reportAnnual Report FiledApr 14, 2026Filing

Questions

Frequently asked questions

What is Legend Biotech Corporation's market cap?

Legend Biotech Corporation (LEGN) has a market capitalization of $5B.

What is LEGN's P/E ratio?

A meaningful P/E ratio is not available for LEGN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LEGN's price-to-book (P/B) ratio?

LEGN trades at 5.03 times book value per share.

Are insiders buying LEGN stock?

SEC Form 4 filings show no open-market insider buys at Legend Biotech Corporation in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

MIRM

Mirum Pharmaceuticals, Inc.

$5.1B

CAI

Caris Life Sciences, Inc.

$4.7B

CRSP

CRISPR Therapeutics AG

$5.4B

CGON

CG Oncology, Inc. Common stock

$5.4B

LGND

Ligand Pharmaceuticals Incorporated

$4.7B

LQDA

Liquidia Corporation

$5.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.